229 related articles for article (PubMed ID: 27465882)
1. Novel oral anticoagulant management issues for the stroke clinician.
Wassef A; Butcher K
Int J Stroke; 2016 Oct; 11(7):759-67. PubMed ID: 27465882
[TBL] [Abstract][Full Text] [Related]
2. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
3. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
4. The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation.
Kuznetsov S; Barcelona R; Josephson RA; Mohan SK
Curr Neurol Neurosci Rep; 2016 May; 16(5):47. PubMed ID: 27023335
[TBL] [Abstract][Full Text] [Related]
5. New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.
Yasaka M
Front Neurol Neurosci; 2015; 37():93-106. PubMed ID: 26588018
[TBL] [Abstract][Full Text] [Related]
6. Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolism.
Bentz BA
J Am Assoc Nurse Pract; 2015 Dec; 27(12):721-31. PubMed ID: 26676209
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
10. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.
Kalabalik J; Rattinger GB; Sullivan J; Slugocki M; Carbone A; Rivkin A
Drugs; 2015 Jun; 75(9):979-98. PubMed ID: 25998374
[TBL] [Abstract][Full Text] [Related]
11. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
Lasek-Bal A; Urbanek T; Gierek D
Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing.
Farmakis D; Davlouros P; Giamouzis G; Giannakoulas G; Pipilis A; Tsivgoulis G; Parissis J
Cardiology; 2018; 140(2):126-132. PubMed ID: 29975925
[TBL] [Abstract][Full Text] [Related]
16. Acute stroke in patients on new direct oral anticoagulants: how to manage, how to treat?
Epple C; Steiner T
Expert Opin Pharmacother; 2014 Oct; 15(14):1991-2001. PubMed ID: 25014495
[TBL] [Abstract][Full Text] [Related]
17. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
Deitelzweig S
Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
[TBL] [Abstract][Full Text] [Related]
18. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
[TBL] [Abstract][Full Text] [Related]
19. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
Oertel LB; Fogerty AE
J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310
[TBL] [Abstract][Full Text] [Related]
20. The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations.
Plitt A; Bansilal S
J Atr Fibrillation; 2017; 9(5):1547. PubMed ID: 29250278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
